Aurinia Pharmaceuticals Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AUPH Nasdaq 2834 www.auriniapharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aurinia Pharmaceuticals Inc.

Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - Jul 2nd, 2025 6:48 am
Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200) - Jun 30th, 2025 4:00 am
Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025 - Jun 29th, 2025 3:00 pm
Exploring Three High Growth Tech Stocks In The US Market - Jun 27th, 2025 11:38 am
Aurinia (AUPH) Surges 7.5%: Is This an Indication of Further Gains? - Jun 27th, 2025 6:56 am
With 51% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns - Jun 15th, 2025 6:56 am
Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock? - May 30th, 2025 6:46 am
New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis - May 22nd, 2025 4:00 am
Aurinia Pharmaceuticals' (NASDAQ:AUPH) Performance Is Even Better Than Its Earnings Suggest - May 19th, 2025 4:36 am
Aurinia Pharmaceuticals Inc. Just Recorded A 60% EPS Beat: Here's What Analysts Are Forecasting Next - May 16th, 2025 1:00 pm
Company News for May 13, 2025 - May 13th, 2025 7:24 am
Aurinia Pharmaceuticals Inc (AUPH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - May 13th, 2025 1:03 am
Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - May 12th, 2025 5:10 am
Aurinia: Q1 Earnings Snapshot - May 12th, 2025 4:07 am
Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025 - May 12th, 2025 4:00 am
Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025 - May 5th, 2025 4:00 am
Glass Lewis Recommends That Aurinia Shareholders Vote "FOR" All Proposals at 2025 Annual General Meeting - Apr 30th, 2025 4:00 am
ISS Recommends That Aurinia Shareholders Vote "FOR" All Proposals at 2025 Annual General Meeting - Apr 29th, 2025 4:00 am
Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics - Apr 24th, 2025 6:56 am
5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms - Apr 23rd, 2025 7:32 am